NG34 presented similar antitumor efficacy in immunocompromised and syngeneic GBM mouse models compared to rQNestin34.5, but NG34 appeared to be less toxic when injected in the brain of non-tumor-bearing mice [76]. Here, C6orf47 is linked to neoplasm.